Marketing & Sales | ABNewswire

JORVEZA Market Outlook 2034: Strong JORVEZA Sales Forecast, Expanding EoE Landscape, and Innovation in Targeted Therapy Drive Growth – Comparative Insights with Miglustat Market Trends | DelveInsight

JORVEZA Sales Forecast The global JORVEZA market is witnessing significant momentum, driven by rising diagnosis rates of eosinophilic esophagitis (EoE), increasing adoption of targeted corticosteroid therapies, and strong clinical outcomes. According to DelveInsight’s latest analysis, the JORVEZA sales forecast is … Continue reading →

OpenClaw.Direct adds ability to hire AI employees through conversation

OpenClaw.Direct provides a complete lifecycle for digital workers. Treating each assistant like an employee, teams hire through conversation, assign a personality that sets tone and expertise, then train with skills from a catalog of more than 1,000 options. They check … Continue reading →

Miglustat Sales Forecast 2034: Miglustat Market Set for Strong Growth Across Rare Lysosomal Disorders, Says DelveInsight

Miglustat Sales The global miglustat market is witnessing steady expansion and is projected to grow significantly through 2034, driven by increasing adoption, expanding patient populations, and rising awareness of rare metabolic disorders. According to DelveInsight’s latest report, “Miglustat Sales Forecast, … Continue reading →

Allergic Conjunctivitis Clinical Trials Landscape 2026: Regulatory Approvals (FDA, EMA, PMDA), Drug Innovations, Mechanisms, Routes of Administration, IND/NDA Progress, and Companies | DelveInsight

Allergic Conjunctivitis Clinical Trials Allergic Conjunctivitis companies actively involved in the developing treatment include Aldeyra Therapeutics, Alcon, Novartis AG, Eyevance Pharmaceuticals LLC, Sun Pharmaceutical, Allergan, AbbVie Inc., Santen Pharmaceutical Co., Bausch & Lomb Incorporated, Ocular Therapeutix, Inc., and others. “Allergic … Continue reading →

Prader-Willi Syndrome Market Size in the 7MM was ~USD 600 million in 2023 and expected to grow by 2034, reveals DelveInsight

Prader-Willi Syndrome Market Key Prader-Willi Syndrome Companies are Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno Therapeutics, Harmony Biosciences, ACADIA Pharmaceuticals, Aardvark Therapeutics, Gedeon Richter, Palobiofarma, ConSynance Therapeutics, and others DelveInsight’s “Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers … Continue reading →

Farm Implements Market worth $66.21 billion by 2032

Farm Implements Market Farm Implements Market by Equipment Type (Cultivators, Tillers, Seeders & Planters, Rotavators, Sprayers, Harvesters, Balers), Operation Type, End-Use (Commercial, Residential, Others), and Region – Global Forecast to 2032 The Farm Implements Market is expected to reach USD … Continue reading →

Sweeter Executes Six-Month Pre-Launch Campaign for SKIN1004’s First U.S. Flagship Store

Sweeter, a New York City-based experiential marketing company, successfully executed a comprehensive multi-phase brand activation campaign for SKIN1004, the Korean skincare brand, leading up to the opening of their first U.S. flagship store in SoHo. Sweeter, a New York City-based … Continue reading →

Parkinson’s Disease Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | AbbVie, Pfizer, Novartis, F. Roche, Kissei Pharma, AstraZeneca, Prevail Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Parkinson’s Disease pipeline constitutes 80+ key companies continuously working towards developing 100+ Parkinson’s Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Systemic Sclerosis Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Boehringer Ingelheim, Roche, Zenyaku Kogyo, Chugai Pharma, Kyowa Kirin, GSK, AstraZeneca, Amgen

The Key Systemic Sclerosis Companies in the market incli d eBoehringer Ingelheim, Roche, Zenyaku Kogyo, Chugai Pharmaceutical, Kyowa Kirin, GSK, AstraZeneca, Amgen, Mitsubishi Tanabe Pharma, Roche (Genentech), Kiniksa Pharmaceuticals, Boehringer Ingelheim, Kyverna Therapeutics, Cabaletta Bio, and others DelveInsight’s report, “Systemic … Continue reading →

TECHSPO London 2026 Unites Business, Tech and Marketing Leaders for High-Impact Expo

London, UK – TECHSPO London Technology Expo returns September 3-4, 2026, to the InterContinental London Park Lane Hotel, uniting business leaders, technologists, marketers, and innovators for a high-impact, two-day showcase of next-generation digital technology. Part of the globally recognized TECHSPO … Continue reading →

Tuesday - April 07, 2026

Category Archives: Marketing & Sales